Skip to main content
Clinical Trials/CTRI/2014/06/004646
CTRI/2014/06/004646Active, not recruitingPhase 2

An open pilot clinical study on Aan maladu [Male Infertility]with the evaluation of trial drug Nerunjil vithai chooranam.

Not provided1 site in 1 country20 target enrollmentStarted: October 5, 2013Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Active, not recruiting
Enrollment
20
Locations
1
Primary Endpoint
Semen Analysis is done before and after treatment.

Study Overview

Brief Summary

Nerunjil vithai chooranam is a polyherbal formulation, main ingredients are asparagus resemosus,mucuna pruriens,tribulus terrestris. In literature all ingredients of NVC have  aphrodisiac action. NVC is a safest and most effective for male infertility. 20 patients included in the trial and trial drug is given and monitered.

Study Design

Study Type
Interventional
Allocation
Not Applicable
Masking
Not Applicable

Eligibility Criteria

Ages
21.00 Year(s) to 45.00 Year(s) (—)
Sex
Male

Inclusion Criteria

  • •Oligospermia, Oligoasthenospermia, Willing to give semen for investigation.

Exclusion Criteria

  • •Diabetes mellitus , Hypertension, Cardiac diseases, Hydrocele, Azoospermia, Vericocele.

Outcomes

Primary Outcomes

Semen Analysis is done before and after treatment.

Time Frame: After 48 days of treatment semen analysis is repeated.

Secondary Outcomes

  • LFT and RFT is measured before and after treatment.(After 48 days of treatment saftey parameters are repeated.)

Investigators

Sponsor
Not provided

Study Sites (1)

Loading locations...

Similar Trials